Design, synthesis, antinociceptive and anti-inflammatory activities of novel piroxicam analogues

Molecules. 2012 Nov 28;17(12):14126-45. doi: 10.3390/molecules171214126.

Abstract

In this paper we report the design, synthesis, antinociceptive and anti-inflammatory activities of a series of benzothiazine N-acylhydrazones 14a–h, planned by structural modification of piroxicam (1), a non steroidal anti-inflammatory drug. Among the synthesized analogues, compounds 14f (LASSBio-1637) and 14g (LASSBio-1639) were identified as novel antinociceptive and anti-inflammatory prototypes, active by oral administration, acting by a mechanism of action that seems to be different from that of piroxicam, since they were inactive as an inhibitor of cyclooxygenase (COX-1 and COX-2) at concentrations of 10 mM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Analgesics* / chemical synthesis
  • Analgesics* / pharmacology
  • Animals
  • Anti-Inflammatory Agents* / chemical synthesis
  • Anti-Inflammatory Agents* / pharmacology
  • Benzothiadiazines / chemical synthesis
  • Benzothiadiazines / pharmacology
  • Cyclooxygenase 1 / chemistry
  • Cyclooxygenase 2 / chemistry
  • Cyclooxygenase Inhibitors / pharmacology*
  • Membrane Proteins / chemistry
  • Mice
  • Molecular Structure
  • Piroxicam* / analogs & derivatives
  • Piroxicam* / chemical synthesis
  • Piroxicam* / chemistry
  • Piroxicam* / pharmacology

Substances

  • Analgesics
  • Anti-Inflammatory Agents
  • Benzothiadiazines
  • Cyclooxygenase Inhibitors
  • Membrane Proteins
  • Piroxicam
  • Ptgs2 protein, mouse
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, mouse